Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Breast Cancer × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 19 Carcinoma, Non-Small-Cell Lung 18 Esophageal Squamous Cell Carcinoma 15 Breast Neoplasms 14 Triple Negative Breast Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 11 Carcinoma, Hepatocellular 11 Stomach Neoplasms 8 Small Cell Lung Carcinoma 8 Uterine Cervical Neoplasms 6 Recurrence 6 Head and Neck Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Transitional Cell 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Rectal Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Carcinoma, Renal Cell 4 Locally Advanced Rectal Cancer 3 Liver Neoplasms 3 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Neoplasms 2 NSCLC 2

Interventions

Fulvestrant 8 olaparib 4 Capecitabine 4 pyrotinib 3 Docetaxel 3 Vinorelbine 2 Trastuzumab 2 Letrozole 2 Alpelisib 2 vandetanib 1 trastuzumab deruxtecan 1 toripalimab 1 talazoparib 1 sacituzumab govitecan 1 pembrolizumab 1 neratinib 1 liposomal doxorubicin 1 exemestane 1 eribulin 1 dalpiciclib 1 ceralasertib 1 cediranib 1 capivasertib 1 abemaciclib 1 Tablets 1 Moxifloxacin 1 Injections 1 Goserelin 1 Gemcitabine 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡